Spinal Cord Decellularized Matrix Scaffold Loaded with Engineered Basic Fibroblast Growth Factor-Overexpressed Human Umbilical Cord Mesenchymal Stromal Cells Promoted the Recovery of Spinal Cord Injury

Wenli He,Chunying Shi,Jia Yin,Feifei Huang,Wenjing Yan,Jin Deng,Bing Zhang,Bin Wang,Haiping Wang
DOI: https://doi.org/10.1002/jbm.b.35131
2023-01-01
Abstract:Spinal cord injury (SCI) will lead to irreversible damage of sensory and motor function of central nervous system, which seriously affects patient's quality of life. A variety of nerve engineering materials carrying various stem cells and cell growth factors had used to promote the repair of SCI, but they could not mimic the actual matric niche at spinal cord to promote cell proliferation and differentiation. Thus, developing novel biomaterial providing better niche of spinal cord is a new strategy to treat the severe SCI. In this study, we constructed porcine spinal cord decellularized matrix scaffold (SC-DM) with biocompatibility to load engineered basic fibroblast growth factor-overexpressing human umbilical cord mesenchymal stromal cells (bFGF-HUCMSCs) for treating SCI. The continuously released bioactive bFGF factors from grafted bFGF-HUCMSCs and three-dimensional niche by SC-DM promoted the differentiation of endogenous stem cells into neurons with nerve conduction function, leading a markedly motor function recovery of SCI. These results indicated that the functional bFGF-HUCMSCs/SC-DM scaffold provided more suitable matric niche for nerve cells, that would be a promising strategy for the clinical application of SCI.
What problem does this paper attempt to address?